Tech Company Financing Transactions
ImCheck Therapeutics Funding Round
On 6/13/2022, ImCheck Therapeutics raised $103 million in Series C funding from Andera Partners, Earlybird Venture Capital and Agent Capital.
Transaction Overview
Company Name
Announced On
6/13/2022
Transaction Type
Venture Equity
Amount
$103,000,000
Round
Series C
Investors
Proceeds Purpose
The proceeds will be used to support the Phase IIa expansion and completion of the randomized, double-blind, placebo-controlled part of the ongoing EVICTION clinical trial evaluating ImCheck's lead candidate ICT01 as a both monotherapy and in combination with a PD-1 inhibitor for a broad range of cancers including solid tumors and hematologic malignancies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
31 chemin Joseph Aiguier CS 70071
MARSEILLE Cedex 09, 13402
France
MARSEILLE Cedex 09, 13402
France
Phone
Website
Email Address
Overview
ImCheck Therapeutics is designing and developing novel immunotherapeutics that target members of the butyrophilin (BTN) and BTN-like (BTNL) superfamily of checkpoint molecules with an initial focus on gamma delta (?9d2) T cells. Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic with a focus on ?9d2 T cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Pierre d'Epenoux
Chief Financial Officer
Hans Christensen
Chief Medical Officer
Paul Frohna
Chief Scientific Officer
Loui Madakamutil
VP - Bus. Development
Claude Knopf
Browse more venture capital transactions:
Prev: 6/13/2022: Crop.Zone venture capital transaction
Next: 6/14/2022: DealHub.io venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs